Drug Evaluation: ADI-PEG-20 -- pegylated arginine deiminase for arginine-auxotrophic cancers.
Resource
Current Opinion in Molecular Therapeutics,8,240-248.
Journal
Current Opinion in Molecular Therapeutics
Journal Issue
8
Pages
240-248
Date Issued
2006-01
Date
2006-01
Author(s)
Shen, LJ
Shen, WC.
SDGs